Literature DB >> 30671696

Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer's Disease.

Sunil Kumar Dubey1, Munnangi Siva Ram2, Kowthavarapu Venkata Krishna2, Ranendra Narayan Saha3, Gautam Singhvi2, Mukta Agrawal4, Swarnlata Saraf5, Shailendra Saraf5,6, Amit Alexander7.   

Abstract

Globally, the central nervous system (CNS) disorders appear as the most critical pathological threat with no proper cure. Alzheimer's disease (AD) is one such condition frequently observed with the aged population and sometimes in youth too. Most of the research utilizes different animal models for in vivo study of AD pathophysiology and to investigate the potency of the newly developed therapy. These in vivo models undoubtably provide a powerful investigation tool to study human brain. Although, it sometime fails to mimic the exact environment and responses as the human brain owing to the distinctive genetic and anatomical features of human and rodent brain. In such condition, the in vitro cell model derived from patient specific cell or human cell lines can recapitulate the human brain environment. In addition, the frequent use of animals in research increases the cost of study and creates various ethical issues. Instead, the use of in vitro cellular models along with animal models can enhance the translational values of in vivo models and represent a better and effective mean to investigate the potency of therapeutics. This strategy also limits the excessive use of laboratory animal during the drug development process. Generally, the in vitro cell lines are cultured from AD rat brain endothelial cells, the rodent models, human astrocytes, human brain capillary endothelial cells, patient derived iPSCs (induced pluripotent stem cells) and also from the non-neuronal cells. During the literature review process, we observed that there are very few reviews available which describe the significance and characteristics of in vitro cell lines, for AD investigation. Thus, in the present review article, we have compiled the various in vitro cell lines used in AD investigation including HBMEC, BCECs, SHSY-5Y, hCMEC/D3, PC-2 cell line, bEND3 cells, HEK293, hNPCs, RBE4 cells, SK-N-MC, BMVECs, CALU-3, 7W CHO, iPSCs and cerebral organoids cell lines and different types of culture media such as SCM, EMEM, DMEM/F12, RPMI, EBM and 3D-cell culture.

Entities:  

Keywords:  Alzheimer’s disease; BCECs; HBMEC; In vitro cell line; SK-N-MC

Mesh:

Year:  2019        PMID: 30671696     DOI: 10.1007/s10571-019-00653-z

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  11 in total

1.  Studies on Regulation of Global Protein Profile and Cellular Bioenergetics of Differentiating SH-SY5Y Cells.

Authors:  Anuj Pandey; Sana Sarkar; Sanjeev Kumar Yadav; Smriti Singh Yadav; Saripella Srikrishna; Mohammad Haris Siddiqui; Devendra Parmar; Sanjay Yadav
Journal:  Mol Neurobiol       Date:  2022-01-13       Impact factor: 5.590

2.  The Protection of Zinc against Acute Cadmium Exposure: A Morphological and Molecular Study on a BBB In Vitro Model.

Authors:  Jacopo J V Branca; Donatello Carrino; Ferdinando Paternostro; Gabriele Morucci; Claudia Fiorillo; Claudio Nicoletti; Massimo Gulisano; Carla Ghelardini; Lorenzo Di Cesare Mannelli; Matteo Becatti; Alessandra Pacini
Journal:  Cells       Date:  2022-05-15       Impact factor: 7.666

3.  HS3ST2 expression induces the cell autonomous aggregation of tau.

Authors:  M B Huynh; N Rebergue; H Merrick; W Gomez-Henao; E Jospin; D S F Biard; D Papy-Garcia
Journal:  Sci Rep       Date:  2022-06-27       Impact factor: 4.996

Review 4.  Cell models for Down syndrome-Alzheimer's disease research.

Authors:  Yixing Wu; Nicole R West; Anita Bhattacharyya; Frances K Wiseman
Journal:  Neuronal Signal       Date:  2022-04-08

5.  Tortoise Plastron and Deer Antler Gelatin Prevents Against Neuronal Mitochondrial Dysfunction In Vitro: Implication for a Potential Therapy of Alzheimer's Disease.

Authors:  Dan Cheng; Xin-Jing Yang; Lu Zhang; Zong-Shi Qin; Wen-Qi Li; Hai-Chun Xu; Zhang-Jin Zhang
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

6.  Evodiamine derivatives improve cognitive abilities in APPswe/PS1ΔE9 transgenic mouse models of Alzheimer's disease.

Authors:  Shuo Pang; Caixian Sun; Shan Gao; Yajun Yang; Xiandao Pan; Lianfeng Zhang
Journal:  Animal Model Exp Med       Date:  2020-06-29

7.  Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP/PS-1 Mice.

Authors:  Liang Kong; Xue-Tao Li; Ying-Nan Ni; Hong-He Xiao; Ying-Jia Yao; Yuan-Yuan Wang; Rui-Jun Ju; Hong-Yan Li; Jing-Jing Liu; Min Fu; Yu-Tong Wu; Jing-Xian Yang; Lan Cheng
Journal:  Int J Nanomedicine       Date:  2020-04-23

Review 8.  Neuroinflammatory In Vitro Cell Culture Models and the Potential Applications for Neurological Disorders.

Authors:  Ye Peng; Shifeng Chu; Yantao Yang; Zhao Zhang; Zongran Pang; Naihong Chen
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

9.  Analysis of L-leucine amino acid transporter species activity and gene expression by human blood brain barrier hCMEC/D3 model reveal potential LAT1, LAT4, B0AT2 and y+LAT1 functional cooperation.

Authors:  Mehdi Taslimifar; Martin Faltys; Vartan Kurtcuoglu; François Verrey; Victoria Makrides
Journal:  J Cereb Blood Flow Metab       Date:  2021-08-24       Impact factor: 6.200

Review 10.  In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration.

Authors:  Marialena Chrysanthou; Ignacio Miro Estruch; Ivonne M C M Rietjens; Harry J Wichers; Tamara Hoppenbrouwers
Journal:  Nutrients       Date:  2022-01-15       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.